These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 19466410)

  • 21. Cross-sectional analysis of the influence of currently known pharmacogenetic modulators on opioid therapy in outpatient pain centers.
    Lötsch J; von Hentig N; Freynhagen R; Griessinger N; Zimmermann M; Doehring A; Rohrbacher M; Sittl R; Geisslinger G
    Pharmacogenet Genomics; 2009 Jun; 19(6):429-36. PubMed ID: 19514130
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Pharmacokinetics of Morphine in Rats with Adjuvant-induced Arthritis.
    Kimura Y; Shibata M; Tamada M; Ozaki N; Arai K
    In Vivo; 2017; 31(5):811-817. PubMed ID: 28882946
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Opioid-related genetic polymorphisms do not influence postoperative opioid requirement: A prospective observational study.
    Aubrun F; Zahr N; Langeron O; Boccheciampe N; Cozic N; Belin L; Hulot JS; Khiami F; Riou B
    Eur J Anaesthesiol; 2018 Jul; 35(7):496-504. PubMed ID: 29474345
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Analgesia and Opioids: A Pharmacogenetics Shortlist for Implementation in Clinical Practice.
    Matic M; de Wildt SN; Tibboel D; van Schaik RHN
    Clin Chem; 2017 Jul; 63(7):1204-1213. PubMed ID: 28637770
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Opioid-induced respiratory depression: ABCB1 transporter pharmacogenetics.
    Sadhasivam S; Chidambaran V; Zhang X; Meller J; Esslinger H; Zhang K; Martin LJ; McAuliffe J
    Pharmacogenomics J; 2015 Apr; 15(2):119-26. PubMed ID: 25311385
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Influence of drug transporters and UGT polymorphisms on pharmacokinetics of phenolic glucuronide metabolite of mycophenolic acid in Japanese renal transplant recipients.
    Miura M; Kagaya H; Satoh S; Inoue K; Saito M; Habuchi T; Suzuki T
    Ther Drug Monit; 2008 Oct; 30(5):559-64. PubMed ID: 18695635
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Clinical response to morphine in cancer patients and genetic variation in candidate genes.
    Ross JR; Rutter D; Welsh K; Joel SP; Goller K; Wells AU; Du Bois R; Riley J
    Pharmacogenomics J; 2005; 5(5):324-36. PubMed ID: 16103897
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The 118 A > G polymorphism in the human mu-opioid receptor gene may increase morphine requirements in patients with pain caused by malignant disease.
    Klepstad P; Rakvåg TT; Kaasa S; Holthe M; Dale O; Borchgrevink PC; Baar C; Vikan T; Krokan HE; Skorpen F
    Acta Anaesthesiol Scand; 2004 Nov; 48(10):1232-9. PubMed ID: 15504181
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Polymorphisms associated with fentanyl pharmacokinetics, pharmacodynamics and adverse effects.
    Saiz-Rodríguez M; Ochoa D; Herrador C; Belmonte C; Román M; Alday E; Koller D; Zubiaur P; Mejía G; Hernández-Martínez M; Abad-Santos F
    Basic Clin Pharmacol Toxicol; 2019 Mar; 124(3):321-329. PubMed ID: 30281924
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Telmisartan pharmacokinetics in Japanese renal transplant recipients.
    Miura M; Satoh S; Inoue K; Saito M; Habuchi T; Suzuki T
    Clin Chim Acta; 2009 Jan; 399(1-2):83-7. PubMed ID: 18838068
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Association of a polymorphism of ABCB1 with obesity in Japanese individuals.
    Ichihara S; Yamada Y; Kato K; Hibino T; Yokoi K; Matsuo H; Kojima T; Watanabe S; Metoki N; Yoshida H; Satoh K; Aoyagi Y; Yasunaga A; Park H; Tanaka M; Nozawa Y
    Genomics; 2008 Jun; 91(6):512-6. PubMed ID: 18442890
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effects of uridine diphosphate glucuronosyltransferase 2B7 and 1A7 pharmacogenomics and patient clinical parameters on steady-state mycophenolic acid pharmacokinetics in glomerulonephritis.
    Joy MS; Boyette T; Hu Y; Wang J; La M; Hogan SL; Stewart PW; Falk RJ; Dooley MA; Smith PC
    Eur J Clin Pharmacol; 2010 Nov; 66(11):1119-30. PubMed ID: 20567810
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effects of ABCB1, ABCC2, UGT2B7 and HNF4α genetic polymorphisms on oxcarbazepine concentrations and therapeutic efficacy in patients with epilepsy.
    Shen C; Zhang B; Liu Z; Tang Y; Zhang Y; Wang S; Guo Y; Ding Y; Wang S; Ding M
    Seizure; 2017 Oct; 51():102-106. PubMed ID: 28837897
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Genetic Contribution in Low Back Pain: A Prospective Genetic Association Study.
    Margarit C; Roca R; Inda MD; Muriel J; Ballester P; Moreu R; Conte AL; Nuñez A; Morales D; Peiró AM
    Pain Pract; 2019 Nov; 19(8):836-847. PubMed ID: 31269327
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The influence of UGT2B7, UGT1A8, MDR1, ALDH, ADH, CYP3A4 and CYP3A5 genetic polymorphisms on the pharmacokinetics of silodosin in healthy Chinese volunteers.
    Wang Z; Xiang Q; Cui Y; Zhao X; Zhou Y
    Drug Metab Pharmacokinet; 2013; 28(3):239-43. PubMed ID: 23257391
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Prolonged central apnoea after intravenous morphine administration in a 12-year-old male with a UGT1A1 loss-of-function polymorphism.
    Toce MS; Kim H; Chung S; Krauss BS
    Br J Clin Pharmacol; 2019 Jan; 85(1):258-262. PubMed ID: 30421550
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A pharmacogenetic study of uridine diphosphate-glucuronosyltransferase 2B7 in patients receiving morphine.
    Sawyer MB; Innocenti F; Das S; Cheng C; Ramírez J; Pantle-Fisher FH; Wright C; Badner J; Pei D; Boyett JM; Cook E; Ratain MJ
    Clin Pharmacol Ther; 2003 Jun; 73(6):566-74. PubMed ID: 12811366
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Genetic variants in ABCB1 and CYP2C19 and cardiovascular outcomes after treatment with clopidogrel and prasugrel in the TRITON-TIMI 38 trial: a pharmacogenetic analysis.
    Mega JL; Close SL; Wiviott SD; Shen L; Walker JR; Simon T; Antman EM; Braunwald E; Sabatine MS
    Lancet; 2010 Oct; 376(9749):1312-9. PubMed ID: 20801494
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Genetic polymorphism of UDP-glucuronosyltransferase 2B7 (UGT2B7) at amino acid 268: ethnic diversity of alleles and potential clinical significance.
    Bhasker CR; McKinnon W; Stone A; Lo AC; Kubota T; Ishizaki T; Miners JO
    Pharmacogenetics; 2000 Nov; 10(8):679-85. PubMed ID: 11186130
    [TBL] [Abstract][Full Text] [Related]  

  • 40. ABC-transporter gene-polymorphisms are potential pharmacogenetic markers for mitoxantrone response in multiple sclerosis.
    Cotte S; von Ahsen N; Kruse N; Huber B; Winkelmann A; Zettl UK; Starck M; König N; Tellez N; Dörr J; Paul F; Zipp F; Lühder F; Koepsell H; Pannek H; Montalban X; Gold R; Chan A
    Brain; 2009 Sep; 132(Pt 9):2517-30. PubMed ID: 19605531
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.